-
272%
Oncquer Germline Mutation Spec ...
Identification of therapeutically relevant gene mutations for CancerOncquer Germline Mutation Spec ...
Identification of therapeutically relevant gene mutations for Cancer -
272%
ONCQUER TM LB 500 GENE PANEL
Identification of therapeutically relevant gene mutations for Cancer -
272%
ONCQUER ASSIST PANEL
Identification of therapeutically relevant gene mutations for Cancer -
272%
OncQuerTM Canassist Test
Identification of therapeutically relevant gene mutations for Cancer -
272%
OncQuer TM IRMA Test
Identification of therapeutically relevant gene mutations for Cancer -
272%
OncQuer TM Endometrial Cancer ...
Identification of therapeutically relevant gene mutations for CancerOncQuer TM Endometrial Cancer ...
Identification of therapeutically relevant gene mutations for Cancer -
272%
ONCQUERTM SARCOMA PANEL
Identification of therapeutically relevant gene mutations for Cancer -
272%
ONCQUER TM TMB Gene Test
Identification of therapeutically relevant gene mutations for Cancer -
272%
ONCQUER CTC TESTING (1 TEST)
Identification of therapeutically relevant gene mutations for Cancer